16.7
Geneesmiddelafgiftesystemen met gereguleerde afgifte: snelheidsgeprogrammeerd I
Snelheidsgeprogrammeerde systemen voor geneesmiddelafgifte zijn ontworpen om geneesmiddelen met specifieke, gecontroleerde snelheden af te geven om co…
Rate-programmed DDS release drugs at controlled rates using approaches such as polymeric matrix, reservoir, osmotic pump, and microchip systems. Rate-programmed drug delivery systems include various types.
In a dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug or the surrounding matrix.
Drugs with slow dissolution rates dissolve gradually, while others transform into slower-dissolving forms upon contact with GI fluids.
Another approach embeds drugs in slowly dissolving matrices or coats them with slow-dissolving materials to control fluid penetration.
In a diffusion-controlled DDS, the release rate depends on the diffusion of dissolved drug molecules through a rate-controlling element that is non-degradable and either water-swellable or insoluble.
Polymers such as xanthan gum, HPMC, and ethyl cellulose are commonly used in these drug delivery systems.
Dissolution and diffusion-controlled DDS combine both mechanisms, using materials that regulate drug release rate through dissolution and diffusion.
View the full transcript and gain access to JoVE Core videos
Q1: What are the main types of rate-programmed drug delivery systems?
Rate-programmed drug delivery systems include dissolution-controlled, diffusion-controlled, and combined dissolution-diffusion-controlled approaches. Dissolution-controlled systems rely on slow drug or matrix dissolution. Diffusion-controlled systems use non-degradable barriers that regulate drug diffusion. Combined systems integrate both mechanisms to achieve precise, sustained release and maintain consistent therapeutic levels.
Q2: How does dissolution control drug release in modified release systems?
In dissolution-controlled systems, release rate depends on how slowly the drug or surrounding matrix dissolves. Drugs with inherently slow dissolution rates, like griseofulvin and digoxin, dissolve gradually in gastrointestinal fluids. Some drugs transform into slower-dissolving forms upon contact with GI fluids, extending release. Embedding drugs in slowly dissolving matrices or coating them with slow-dissolving materials further regulates fluid penetration and delays drug release.
Q3: What role do polymers play in diffusion-controlled drug delivery?
Polymers form rate-controlling barriers that regulate drug diffusion without dissolving or degrading. Water-swellable polymers like xanthan gum, HPMC, and alginates absorb fluid while maintaining structural integrity. Water-insoluble polymers such as ethyl cellulose and polymethacrylates create stable diffusion barriers. These materials ensure steady, predictable drug release by controlling how dissolved drug molecules pass through the barrier.
Q4: How do combined dissolution-diffusion systems improve drug delivery control?
Combined dissolution-diffusion-controlled systems integrate slow-dissolving coatings with diffusion barriers to enhance release precision. By utilizing materials that influence both dissolution and diffusion processes simultaneously, these hybrid designs achieve superior control over drug release rates. This dual-mechanism approach provides flexible solutions for medications requiring prolonged absorption, improving patient compliance and treatment efficiency.
Q5: What is the difference between water-swellable and water-insoluble polymers in drug delivery?
Water-swellable polymers like xanthan gum and HPMC absorb gastrointestinal fluids while remaining structurally intact, allowing controlled drug diffusion through the swollen matrix. Water-insoluble polymers such as ethyl cellulose and polymethacrylates do not absorb fluid but form impermeable barriers that regulate drug passage. Both types maintain non-degradable, stable structures throughout drug delivery, ensuring predictable release kinetics.
Q6: Why are rate-programmed systems beneficial for patient compliance?
Rate-programmed systems maintain consistent therapeutic drug levels by releasing medication at controlled rates, reducing dosing frequency and improving patient compliance. By providing prolonged absorption and sustained therapeutic effects, these systems enhance treatment efficiency and reduce the burden of frequent medication administration. This controlled approach ensures better therapeutic outcomes while minimizing side effects associated with fluctuating drug concentrations.
Q7: How do drugs like ferrous sulfate behave differently in dissolution-controlled systems?
Ferrous sulfate transforms into a slower-dissolving form when exposed to gastrointestinal fluids, extending its release profile in dissolution-controlled systems. This chemical transformation upon contact with GI fluids naturally slows drug dissolution, allowing gradual absorption. Such drugs demonstrate how dissolution-controlled systems can exploit inherent drug properties to achieve sustained release without requiring additional matrix or coating materials.